Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance

BACKGROUND: There is a need for postmarketing evidence generation for novel biologics and biosimilars. OBJECTIVE: To assess the feasibility, strengths, and limitations of the Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Distributed Research Network (DRN) to examine the utiliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jie, Sridhar, Gayathri, Barr, Charles E., Eichelberger, Bernadette, Lockhart, Catherine M., Marshall, James, Clewell, Jerry, Accortt, Neil A., Curtis, Jeffrey R., Holmes, Cynthia, McMahill-Walraven, Cheryl N., Brown, Jeffrey S., Haynes, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391097/
https://www.ncbi.nlm.nih.gov/pubmed/32223608
http://dx.doi.org/10.18553/jmcp.2020.26.4.417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391097/
https://www.ncbi.nlm.nih.gov/pubmed/32223608
http://dx.doi.org/10.18553/jmcp.2020.26.4.417

Ejemplares similares